Studies on the biologic activities of Sandimmun metabolites in humans and in animal models: review and original experiments.
Fahr
A
A
Department of Pharmacological Development, Sandoz Pharmaceuticals Ltd, Basel, Switzerland.
Hiestand
P
P
Ryffel
B
B
D000818:Animals; D003524:Cyclosporins / Q000493:pharmacokinetics / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007376:Interleukin-2 / Q000235:genetics; D008213:Lymphocyte Activation / Q000187:drug effects*; D007959:Lymphocyte Culture Test, Mixed; D051379:Mice; D008815:Mice, Inbred Strains; D012333:RNA, Messenger / Q000187:drug effects; D013329:Structure-Activity Relationship; D013601:T-Lymphocytes / Q000187:drug effects
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D012333:RNA, Messenger